Relay Therapeutics (RLAY) Other Operating Expenses (2021 - 2024)
Relay Therapeutics (RLAY) posted quarterly Other Operating Expenses of -$11.4 million for Q2 2024, down 428.53% year-over-year from $3.5 million in Q3 2023, and down 520.85% quarter-over-quarter from -$1.8 million in Q1 2024.
Relay Therapeutics (RLAY) Other Operating Expenses (2021 - 2024) Analysis & Trends
Relay Therapeutics (RLAY) has reported Other Operating Expenses for 4 consecutive years, with -$11.4 million the latest figure, recorded in Q2 2024.
- In Q2 2024, Other Operating Expenses fell 428.53% year-over-year to -$11.4 million; the TTM figure through Mar 2025 stood at -$11.4 million (down 56.86% YoY), while the FY2024 annual figure was -$13.2 million, down 105.64% from the prior year.
- Other Operating Expenses slipped to -$11.4 million in Q2 2024 per RLAY's latest filing, from -$1.8 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $134.9 million in Q2 2021 and bottomed at -$11.4 million in Q2 2024.
- Historically, Other Operating Expenses has averaged $8.2 million across 4 years, with a median of -$1.2 million in 2023.
- Annual changes were most pronounced in 2022 — Other Operating Expenses tumbled 1361.24% — and 2023, when it jumped 80.4%.
- Relay Therapeutics' Other Operating Expenses stood at $836000.0 in 2021, then sank by 1361.24% to -$10.5 million in 2022, then surged by 80.4% to -$2.1 million in 2023, then tumbled by 450.27% to -$11.4 million in 2024.
- Business Quant data shows RLAY's Other Operating Expenses at -$11.4 million in Q2 2024, -$1.8 million in Q1 2024, and -$2.1 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Relay Therapeutics | 4.34 Bn | 4.34 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -11.37 Mn |
| Mar 31, 2024 | -1.83 Mn |
| Dec 31, 2023 | -2.07 Mn |
| Sep 30, 2023 | -1.20 Mn |
| Jun 30, 2023 | -2.15 Mn |
| Mar 31, 2023 | -1.00 Mn |
| Dec 31, 2022 | -10.54 Mn |
| Sep 30, 2022 | 3.26 Mn |
| Jun 30, 2022 | 200,000.00 |
| Mar 31, 2022 | -4.60 Mn |
| Dec 31, 2021 | 836,000.00 |
| Sep 30, 2021 | 2.00 Mn |
| Jun 30, 2021 | 134.86 Mn |